Document is current

Article History

Received: 14 January 2025

Accepted: 29 April 2025

First Online: 14 May 2025

Declarations

:

: The study protocol (version 2.0) was approved by the Biomedical Ethics Committee of West China Hospital of Sichuan University (Approval Number: 2018–82) on February 18, 2019. The participants were explained in detail about the purpose of the study, assurance of their confidentiality and privacy of their information, and their voluntary nature of participation. Written informed consent was provided by each participant, and they were fully aware that they can stop cooperation or withdraw at any given time without any reason. A copy of the written informed consent is available for review upon request to the corresponding author or the Editor-in-Chief of this journal.

: Written informed consent was obtained from the patient for publication of this case report and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal on request.

: The authors declare no competing interests.

: (1) Name of the registry: The National Institutes of Health Clinical Trials Registry. (2) Unique identifying number or registration ID: NCT03517098. (3) Hyperlink to the registration (must be publicly accessible and will be checked):

: The corresponding author, Dr. Ren Liao, is the guarantor of this study and accept full responsibility for the work and/or the conduct of the study, had access to the data, and controlled the decision to publish.